Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 81-90 of 172

Page
per page
  1. Tubastatin A
    A4101 Tubastatin A
     6 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥10.75 mg/mL
  2. Etoposide
    A1971 Etoposide
     4 Citation
    Target: Topoisomerases
    Summary: Topo II inhibitor
      ≥29.45 mg/mL
  3. Olaparib (AZD2281, Ku-0059436)
    A4154 Olaparib (AZD2281, Ku-0059436)
     12 Citation
    Summary: Potent PARP1/PARP2 inhibitor
      ≥21.72 mg/mL
  4. Idarubicin HCl
    A2476 Idarubicin HCl
    Summary: Anthracycline and daunorubicin analog,topoisomerase inhibitor
      ≥26.7 mg/mL
  5. WIKI4
    A4531 WIKI4
    Summary: Inhibitor of Wnt/ß-Catenin signaling and tankyrase
      ≥26.1 mg/mL
  6. ABT-888 (Veliparib)
    A3002 ABT-888 (Veliparib)
     6 Citation
    Summary: Potent PARP inhibitor
  7. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  8. MK-4827
    A3617 MK-4827
    Target: PARP
    Summary: PARP-1/-2 inhibitor,potent and selective
      ≥32 mg/mL
  9. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  10. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL

Items 81-90 of 172

Page
per page
Shop By
Now Shopping by
  1. Category DNA Damage/DNA Repair Remove This Item
Clear All
Shopping Options
Category
  1. MTH1 4item
  2. PARP 32item
  3. ATM/ATR 10item
  4. DNA Alkylating 1 item
  5. DNA Ligases 3item
  6. DNA Methyltransferase 1 item
  7. DNA-PK 8item
  8. DNA Synthesis 26item
  9. HDAC 52item
  10. Nucleoside Antimetabolite/Analogue 4item
  11. Telomerase 3item
  12. Topoisomerase 25item
  13. tankyrase 5item
Specificity
  1. Selective 59item
Reversibility
  1. Reversible 4item
Target
  1. Histone Deacetylases (HDACs) 33item
  2. PI3K 5item
  3. mTOR 1 item
  4. Thymidylate Synthase 2item
  5. STAT 1 item
  6. EGFR 1 item
  7. Tankyrases 1 item
  8. DNA-PK 4item
  9. TNKS 1 item
  10. Topoisomerases 9item
  11. ErbB 1 item
  12. PARP 7item
  13. ATM/ATR 6item
  14. AP endonucleases 1 item
  15. HSV 1 item
  16. FoxM1 1 item
  17. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  18. HDAC 1 item
  19. KDM 1 item
  20. HCV polymerase 1 item
  21. telomerase 1 item
  22. Ribonucleotide Reductases 1 item
  23. Adenosine Deaminases 1 item
  24. DNA Ligases 1 item
  25. PHF 1 item
  26. ATM 2item
  27. MTH1 1 item
Reported Experiments
  1. Animal Experiments 70item
  2. Cell Experiments 61item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 1 item
  3. Bladder Cancer 3item
  4. Breast Cancer 17item
  5. Cancer 54item
  6. Chronic Lymphocytic Leukemia 1 item
  7. Colon Cancer 9item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 6item
  10. Dyskinesia 1 item
  11. Epilepsy 1 item
  12. Friedreich's Ataxia 1 item
  13. Glioma 2item
  14. HCV 1 item
  15. Hepatic Cancer 1 item
  16. Hepatocellular Carcinoma 3item
  17. HIV Infections 1 item
  18. Inflammatory Diseases 1 item
  19. Leukemia 4item
  20. Liver Cancer 1 item
  21. Lung Cancer 5item
  22. Lymphoma 5item
  23. Melanoma 2item
  24. Multiple Myeloma 3item
  25. Myeloma 2item
  26. Neuroblastoma 2item
  27. Neuronal Protection 1 item
  28. Non-small Cell Lung Cancer 3item
  29. Ovarian Cancer 6item
  30. Pancreatic Cancer 3item
  31. Prostate Cancer 8item
  32. Renal Cancer 1 item
  33. Renal Cell Carcinoma 2item
  34. Testicular Cancer 1 item